- By Taylor Leigh
- Posted November 10, 2017
Why Genetic Counselors are Integral to Ambry
In our more than 20 years of operation, Ambry has come a long way. Looking back, it’s important to remember that we would not be “Ambry Genetics” without our genetic counselors. Ambry is built on the foundation of quality genetic testing that helps people find answers – and genetic counselors have been with us from the beginning, working…
- By Aaron Schmidt
- Posted October 23, 2017
Ambry Contributes to the Genetic Community’s Scientific Knowledge at ASGH
Ambry strives to always present impactful research that moves the science of genetics forward at tradeshows and conferences throughout the year. Below, are summaries of the research we presented at this year's American Society of Human Genetic's Annual Meeting. Black, M.H., et al: Type 2 Diabetes Variants Contribute to Breast Cancer Risk…
- By Tiffany Au
- Posted October 19, 2017
Ambry Honored as Member of the Civic 50 Orange County
Ambry was founded on a single vision, with a single mission, by a single person – Charles Dunlop. He believed the world would be a better place if all human disease was understood. Fueled by this vision and frustrated with the politics of academia during his education, Charlie built a genetics lab with a group of scientists whose only goal was…
- By Souzan El-Eid, MD, FACS
- Posted October 17, 2017
A Breast Cancer Surgeon Offers Perspective on Patient Care
An estimated 252,710 women will be diagnosed with breast cancer in 2017.1 Early detection of breast cancer is critical for successful treatment of this disease - women who are diagnosed with early stage/localized breast cancer have a 5-year survival rate of 98.9% 1 We hope that this Breast Cancer Awareness Month will inspire more people to discuss…
- By Jessica Profato, MS, CGC
- Posted October 16, 2017
Identifying Patients with Lynch Syndrome: A Paired Somatic/Germline Testing Approach
Lynch syndrome is one of the most common hereditary cancer syndromes, affecting about 1/279-1/440 people in the U.S. It is caused by a genetic mutation in one of five genes: MLH1, MSH2, MSH6, PMS2, or EPCAM. Individuals with Lynch syndrome have a significantly increased lifetime risk for multiple types of cancer including colorectal…
- By Aaron Schmidt
- Posted October 13, 2017
Ambry’s NSGC Research Paves the Way for Future Scientific Discovery, Clinical Practice Enhancements
In our quest to understand all human disease, Ambry employs a team of researchers who investigate topics from every area of genetics research. Throughout her tenure at Ambry, Zoe Powis, MS CGC, Supervisor of Clinical Genomics Research, has contributed much to the broader body of knowledge about the field of genetics. At this year’s National…
- By Aaron Schmidt
- Posted October 9, 2017
Ambry's Research at the National Society of Genetic Counselors 2017 Annual Meeting
We present impactful research to move the science of genetics forward at tradeshow and conferences throughout the year. Check out some of the research, separated by category below, that we brought to this year’s National Society of Genetic Counselor’s annual meeting. Read about the contributions from our lead researcher Zoe Powis and the Ambry…
- By Laura Panos Smith
- Posted October 4, 2017
Hereditary Cancer Tests: Is Bigger Always Better?
Just five short years ago, hereditary cancer testing was much simpler for patients and healthcare providers. There were finite criteria, associated with a handful of genetic conditions, and healthcare providers could order single-gene (or single-syndrome) genetic testing for patients who met those criteria. Since 2012, the field of genetics has…
- By James L. Wilder, MD
- Posted September 11, 2017
The Benefits of Genetic Testing for Your GYN/ONC Practice
An estimated 22,440 women will be diagnosed with ovarian cancer in 2017. Early detection is critical for successful treatment of this disease, which has a 5-year survival rate of 92.5% for women who are diagnosed with early stage/localized ovarian cancer.1 We hope that Ovarian Cancer Awareness Month will bring more women to their healthcare providers…
- By Brian Helfand, MD, PhD
- Posted September 7, 2017
How Genetic Testing Can Benefit Your Urology Practice
An estimated 161,360 men will be diagnosed with prostate cancer in 2017; early detection is critical for successful treatment of this disease. We hope that Prostate Cancer Awareness Month will bring more men to their healthcare providers asking about prostate cancer screening or about their risk of developing this disease. Genetic testing for…